LabVantage Pharma

This paper outlines the requirements of 21 CFR Part 11 and Annex 11, and provides information on how LabVantage software supports customers in complying with the regulations. The LabVantage software includes its laboratory information management system (LIMS), electronic laboratory notebook (ELN), and laboratory execution system (LES).

With the explosive growth in the number of specimens stored in biobanks, leading biobanking institutions are striving to better organize their sample inventory and associated data. A biobanking informatics system is essential to ensure sample viability, inventory and data fidelity for the future. In this case study, learn why the Duke Biobank, based in the Duke Translational Medicine Institute of Duke Medicine, adopted LabVantage as its laboratory information management system (LIMS) in order to improve management of sample inventories in multiple biobanking entities.

Biobanks play a crucial role in biomedical research by storing and distributing a wide array of biospecimens and the clinical information linked to those samples. Many challenges are encountered when biobanking, including the tracing of samples and security of patient information. This application note details how a LabVantage purpose-built, commercial-off-the-shelf (COTS) Biobanking LIMS solution can help address many of these challenges by providing built-in workflows, electronic data capture, improved data accuracy and increased process efficiency, as well as enabling compliance with regulatory requirements.

Multiple enhancements in LabVantage 8.3

LabVantage 8 Pharma provides pre-configured LIMS